Renasant Bank Vertex Pharmaceuticals Inc Transaction History

Renasant Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$407.69 - $446.08 $4,484 - $4,906	-11 Reduced 2.03%	532 $222,000
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $186,249 - $222,999	543 New	543 $220,000
Q1 2023 May 05, 2023	SELL	$283.23 - $323.1 $87,801 - $100,161	-310 Reduced 31.99%	659 $207,000
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $276,901 - $311,514	969 New	969 $279,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

Stay updated on Renasant Bank with notifications on news.